logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Mototsugu Oya

keio university

61H指数
1.2K论文数
1.7W被引数
收录论文 352
发表时间
logo
A Case of Testicular Malakoplakia With Markedly High Signal Intensity on Fat-Suppressed T1-Weighted Images一例睾丸软斑症，在脂肪抑制T1加权图像上呈现明显高信号强度
errIJU Case Reports
IF0.6
err2026-04-27
err1
PREAI
errYagi, Fumiko; Akita, Hirotaka; Kosaka, Takeo; Ueno, Akihisa; Kotera, Teppei; Kobayashi, Masato; Mekada, Hideaki; Oya, Mototsugu; Jinzaki, Masahiro
err分享
err收藏
Genomic alteration and clinical significance of circulating tumor DNA in patients with advanced urothelial cancer: SCRUM-Japan monstar screen project基因组改变和循环肿瘤DNA在晚期尿路上皮癌患者中的临床意义：日本SCRUM-monstar筛查项目
errnpj Precision Oncology
IF8
err2025-11-18
err0
errOAAI
errTakahiro Osawa; Nobuaki Matsubara; Taigo Kato; Masaki Shiota; Koshiro Nishimoto; Takashige Abe; Nobuo Shinohara; Yota Yasumizu; Nobuyuki Tanaka; Mototsugu Oya; Hikaru Abutani; Takaaki Oda; Takao Fujisawa; Yoshiaki Nakamura; Smruthy Sivakumar; Masatoshi Eto; Takayuki Yoshino; Norio Nonomura
err分享
err收藏
Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study在PROpel III期研究中，接受奥拉帕利联合阿比特龙治疗或安慰剂联合阿比特龙治疗转移性去势抵抗性前列腺癌患者的患者报告结局。
errEuropean Urology Oncology
IF9.3
err2025-11-17
err0
errOAAI
errAndrew J. Armstrong; Fred Saad; Mototsugu Oya; Karina Vianna; Mustafa Özgüroğlu; Craig Gedye; Gary L. Buchschacher; Ji Youl Lee; Urban Emmenegger; Jiří Navrátil; Juan Antonio Virizuela; Anibal Salazar; Denis Maillet; Hiroji Uemura; Christian Hosius; David McGuinness; Arnold Degboe; Noel Clarke
err分享
err收藏
ASO Author Reflections: Advancing AI-Based Surgical Phase Recognition in Robot-Assisted Radical ProstatectomyASO作者反思：推进基于AI的机器人辅助根治性前列腺切除术中的手术阶段识别
errAnnals of Surgical Oncology
IF3.5
err2025-11-13
err0
PREAI
errYuichiro Konnai; Keishiro Fukumoto; Masashi Takeuchi; Rei Takeuchi; Shinnosuke Fujiwara; Yota Yasumizu; Nobuyuki Tanaka; Toshikazu Takeda; Kazuhiro Matsumoto; Takeo Kosaka; Hirofumi Kawakubo; Yuko Kitagawa; Mototsugu Oya
err分享
err收藏
Prostate-specific Antigen and Objective Response Analyses in PROpel: Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone as First-line Therapy for Metastatic Castration-resistant Prostate Cancer前列腺特异性抗原和客观缓解分析在PROpel研究中：奥拉帕利联合阿比特龙对比安慰剂联合阿比特龙作为转移性去势抵抗性前列腺癌的一线疗法
errEuropean Urology Oncology
IF9.3
err2025-11-04
err0
errOAAI
errFred Saad; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Emma Brown; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; Elizabeth A. Harrington; Jinyu Kang; Noel Clarke
err分享
err收藏
Expression of Glucocorticoid Receptor and FOXO1/phospho-FOXO1 in Bladder Cancer as Independent Prognosticators
errCANCER GENOMICS & PROTEOMICS
IF2.6
err2025-11-01
err0
PREAI
errIde, Hiroki; Najafi, Mohammad Amin Elahi; Matsukawa, Takuo; Tatenuma, Tomoyuki; Oya, Mototsugu; Miyamoto, Hiroshi
err分享
err收藏
GWAS Identifies SNPs Associated With Severe Adverse Events and Efficacy in Advanced Renal Cell Carcinoma Treated With Nivolumab全基因组关联研究（GWAS）鉴定出与接受纳武利尤单抗治疗的晚期肾细胞癌患者严重不良事件及疗效相关的单核苷酸多态性（SNP）。
errCancer Science
IF4.3
err2025-09-24
err0
errOAAI
errTokiyoshi Tanegashima; Masaki Shiota; Shusuke Akamatsu; Hideaki Miyake; Masayuki Takahashi; Mototsugu Oya; Norihiko Tsuchiya; Naoya Masumori; Hideyasu Matsuyama; Wataru Obara; Nobuo Shinohara; Kiyohide Fujimoto; Masahiro Nozawa; Kojiro Ohba; Chikara Ohyama; Katsuyoshi Hashine; Tomomi Kamba; Koji Mita; Momokazu Gotoh; Shuichi Tatarano; Masato Fujisawa; Yoshihiko Tomita; Shoichiro Mukai; Keiichi Ito; Shoji Tokunaga; Masatoshi Eto; SNiP-RCC investigators
err分享
err收藏
Correction: Androgen receptor signaling induces hemorrhage and angiogenesis in the irradiated bladder更正：雄激素受体信号诱导照射膀胱中的出血和血管生成
errScientific Reports
IF3.9
err2025-09-12
err0
errOAAI
errTakahiro Komori; Hiroki Ide; Junichi Fukada; Yuto Baba; Kazuhiro Matsumoto; Hiroshi Miyamoto; Mototsugu Oya
err分享
err收藏
High Absolute Monocyte Count Predicts Poor Clinical Outcome in Patients with Castration-Resistant Prostate Cancer Treated with Docetaxel Chemotherapy (vol 23, pg 4115, 2016)高绝对单核细胞计数预测接受多西他赛化疗的去势抵抗性前列腺癌患者不良临床结局（vol 23, pg 4115, 2016）
errANNALS OF SURGICAL ONCOLOGY
IF3.5
err2025-05-08
err0
PREAI
errShigeta, Keisuke; Kosaka, Takeo; Kitano, Shigehisa; Yasumizu, Yota; Miyazaki, Yasumasa; Mizuno, Ryuichi; Shinojima, Toshiaki; Kikuchi, Eiji; Miyajima, Akira; Tanoguchi, Hitoshi; Hasegawa, Shintaro; Oya, Mototsugu
err分享
err收藏
Corrigendum to “Profiling FGFR3 Expression Based on the Immune Micro-environment in Upper Tract Urothelial Carcinoma” [Eur. Urol. Oncol. 7(6) (2024) 1338-1349]勘误：“基于上尿路尿路上皮癌免疫微环境分析FGFR3表达特征”[Eur. Urol. Oncol. 7(6) (2024) 1338-1349]
errEuropean Urology Oncology
IF9.3
err2025-05-06
err0
errOAAI
errKeisuke Shigeta; Kazuhiro Matsumoto; Sotaro Kitaoka; Minami Omura; Kota Umeda; Yuki Arita; Shuji Mikami; Keishiro Fukumoto; Yota Yasumizu; Nobuyuki Tanaka; Toshikazu Takeda; Shinya Morita; Takeo Kosaka; Ryuichi Mizuno; Satoshi Hara; Mototsugu Oya
err分享
err收藏
Adverse events of hepatic function disorder in Japanese patients with radically unresectable or metastatic renal cell carcinoma treated with pembrolizumab plus axitinib: a post-marketing surveillance study日本接受帕博利珠单抗联合阿昔替尼治疗根治性不可切除或转移性肾细胞癌患者的肝功能紊乱不良事件：一项上市后监测研究
errinternational journal of oncology
IF2.8
err2025-04-29
err0
errOAAI
errOya, Mototsugu; Yasuoka, Shotaro; Tokudome, Takuto; Minegishi, Toshihiko; Hamada, Masahiro; Ozaki, Masahiko; Maekawa, Shinichiroh; Ito, Yuichiro
err分享
err收藏
Applicability of the regression approach for histological multi-class grading in clear cell renal cell carcinoma
errREGENERATIVE THERAPY
IF3.5
err2025-03-01
err0
PREAI
errShibata, Mayu; Umezawa, Akihiro; Aoto, Saki; Okamura, Kohji; Nasu, Michiyo; Mizuno, Ryuichi; Oya, Mototsugu; Yura, Kei; Mikami, Shuji
err分享
err收藏
Real-world outcomes with avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: subgroup analyses from the J-DART2 study by International Metastatic Renal Cell Carcinoma Database Consortium risk classification日本晚期肾细胞癌患者接受阿维鲁姆单抗联合阿昔替尼治疗的实际世界结局：基于国际转移性肾细胞癌数据库联盟风险分类的J-DART2研究亚组分析
errinternational journal of oncology
IF2.8
err2025-02-11
err0
errOAAI
errFurukawa, Junya; Kato, Taigo; Yamasaki, Toshinari; Monji, Keisuke; Tanaka, Toshiaki; Tsuchiya, Norihiko; Miyagawa, Tomoaki; Yaegashi, Hiroshi; Sano, Tomoyasu; Karashima, Takashi; Fujita, Kazutoshi; Hori, Jun-ichi; Ito, Takayuki; Kajita, Masahiro; Tomita, Yoshihiko; Shinohara, Nobuo; Eto, Masatoshi; Oya, Mototsugu; Uemura, Hirotsugu
err分享
err收藏
Final Analysis of Post-Marketing Surveillance for Avelumab plus Axitinib in Patients With Renal Cell Carcinoma in Japan日本肾细胞癌患者中阿维鲁姆单抗联合阿昔替尼上市后监测的最终分析
errCANCER MEDICINE
IF3.1
err2025-01-21
err0
errOAAI
errNonomura, Norio; Ito, Taito; Sato, Masashi; Morita, Makiko; Ogi, Mie; Kajita, Masahiro; Oya, Mototsugu
err分享
err收藏
Avelumab plus axitinib treatment in older patients with advanced renal cell carcinoma in Japan: Subgroup analyses of post-marketing surveillance data by ageavelumab联合axitinib治疗在日本老年晚期肾细胞癌患者中的应用：按年龄划分的上市后监测数据亚组分析
errCANCER MEDICINE
IF3.1
err2025-01-21
err0
errOAAI
errOya, Mototsugu; Ito, Taito; Sato, Masashi; Morita, Makiko; Kajita, Masahiro; Nonomura, Norio
err分享
err收藏
Profiling Fibroblast Growth Factor Receptor 3 Expression Based on the Immune Microenvironment in Upper Tract Urothelial Carcinoma
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2024-12-01
err0
errOAAI
errShigeta, Keisuke; Matsumoto, Kazuhiro; Kitaoka, Sotaro; Omura, Minami; Umeda, Kota; Arita, Yuki; Mikami, Shuji; Fukumoto, Keishiro; Yasumizu, Yota; Tanaka, Nobuyuki; Takeda, Toshikazu; Morita, Shinya; Kosaka, Takeo; Mizuno, Ryuichi; Hara, Satoshi; Oya, Mototsugu
err分享
err收藏
Efficacy and Safety of Olaparib Plus Abiraterone Versus Placebo Plus Abiraterone in the First-line Treatment of Patients with Asymptomatic/Mildly Symptomatic and Symptomatic Metastatic Castration-resistant Prostate Cancer: Analyses from the Phase 3 PROpel Trial奥拉帕利联合阿比特龙对比安慰剂联合阿比特龙在无症状/轻度症状及症状性转移性去势抵抗性前列腺癌患者一线治疗中的有效性和安全性：来自III期PROpel试验的分析
errEuropean Urology Oncology
IF9.3
err2024-10-01
err0
errOAAI
errNoel W. Clarke; Andrew J. Armstrong; Mototsugu Oya; Neal Shore; Giuseppe Procopio; João Daniel Guedes; Cagatay Arslan; Niven Mehra; Francis Parnis; Emma Brown; Friederike Schlürmann; Jae Young Joung; Mikio Sugimoto; Oliver Sartor; Christian Poehlein; David McGuinness; Arnold Degboe; Fred Saad
err分享
err收藏
Multiplexed Spatial Imaging at the Single-Cell Level Reveals Mutually Exclusive Expression of B7 Family Proteins
errLABORATORY INVESTIGATION
IF4.2
err2024-10-01
err0
PREAI
errShojo, Kazunori; Tanaka, Nobuyuki; Murakami, Tetsushi; Anno, Tadatsugu; Teranishi, Yu; Takamatsu, Kimiharu; Mikami, Shuji; Imamura, Takeshi; Matsumoto, Kazuhiro; Oya, Mototsugu
err分享
err收藏
Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2024-08-22
err5
PREAI
errChoueiri, T. K.; Powles, T.; Peltola, K.; de Velasco, G.; Burotto, M.; Suarez, C.; Ghatalia, P.; Iacovelli, R.; Lam, E. T.; Verzoni, E.; Gumus, M.; Stadler, W. M.; Kollmannsberger, C.; Melichar, B.; Venugopal, B.; Gross-Goupil, M.; Poprach, A.; De Santis, M.; Schutz, F. A.; Park, S. H.; Nosov, D. A.; Porta, C.; Lee, J. L.; Garcia-del-Muro, X.; Biscaldi, E.; Kopp, R. Manneh; Oya, M.; He, L.; Wang, A.; Perini, R. F.; Vickery, D.; Albiges, L.; Rini, B.
err分享
err收藏
Effect of HLA Genotype on Anti-PD-1 Antibody Treatment for Advanced Renal Cell Carcinoma in the SNiP-RCC Study
errJOURNAL OF IMMUNOLOGY
IF3.4
err2024-05-17
err0
errOAAI
errTanegashima, Tokiyoshi; Shiota, Masaki; Fujiyama, Nobuhiro; Narita, Shintaro; Habuchi, Tomonori; Fukuchi, Genshiro; Takamatsu, Dai; Oda, Yoshinao; Miyake, Hideaki; Takahashi, Masayuki; Oya, Mototsugu; Tsuchiya, Norihiko; Masumori, Naoya; Matsuyama, Hideyasu; Obara, Wataru; Shinohara, Nobuo; Fujimoto, Kiyohide; Nozawa, Masahiro; Ohba, Kojiro; Ohyama, Chikara; Hashine, Katsuyoshi; Akamatsu, Shusuke; Kamba, Tomomi; Mita, Koji; Gotoh, Momokazu; Tatarano, Shuichi; Fujisawa, Masato; Tomita, Yoshihiko; Mukai, Shoichiro; Ito, Keiichi; Tokunaga, Shoji; Eto, Masatoshi
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
K
Karl Deisseroth
H 指数: 182 · 论文数: 636
T
Toni K. Choueiri
H 指数: 149 · 论文数: 2.4K
R
Robert J. Motzer
H 指数: 148 · 论文数: 1.6K
F
Francesco Montorsi
H 指数: 146 · 论文数: 4.1K
S
Shahrokh F. Shariat
H 指数: 146 · 论文数: 2.9K
查看更多